REQUEST A DEMO
Total
USD $0.00
Search more companies

Xinetix Pharma S A S (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Xinetix Pharma S A S Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Xinetix Pharma S A S is a company based in Colombia, with its head office in Bogota D.C.. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on March 05, 2014. 33 (2024) employees currently work for Xinetix Pharma S A S. The latest financial highlights indicate a net sales revenue increase of 162% in 2023. Its total assets grew by 60.28% over the same period. In 2023, Xinetix Pharma S A S’s net profit margin increased by 4.53%.

Headquarters
Cr 55 No 152 B - 68 Of 1201
Bogota D.C.; Bogota D.C; Postal Code: 1104

Contact Details: Purchase the Xinetix Pharma S A S report to view the information.

Basic Information
Total Employees:
Purchase the Xinetix Pharma S A S report to view the information.
Outstanding Shares:
Purchase the Xinetix Pharma S A S report to view the information.
Incorporation Date:
March 05, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Xinetix Pharma S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
162%
Total operating revenue
162%
Operating profit (EBIT)
1475.48%
Net Profit (Loss) for the Period
1235.39%
Total assets
60.28%
Total equity
79.13%
Operating Profit Margin (ROS)
13.88%
Net Profit Margin
4.53%
Return on Equity (ROE)
38.25%
Quick Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?